跳转至内容
Merck

SML0184

Sigma-Aldrich

人参皂苷 Rg3

≥98% (HPLC)

别名:

(3β, 12β)-12,20-二羟基 dmar-24-烯-3-基 2- O -β- D -吡喃葡萄糖基-β- D -吡喃葡萄糖苷, 20 (S)-人参皂苷-Rg3, Rg3

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C42H72O13
CAS号:
分子量:
785.01
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

光學活性

[α]/D +10 to +20°, c = 1 in methanol

儲存條件

desiccated

顏色

white to beige

溶解度

DMSO: ≥5 mg/mL

儲存溫度

2-8°C

SMILES 字串

C\C(C)=C\CC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]3[C@@]4(C)CC[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]4CC[C@@]23C

InChI

1S/C42H72O13/c1-21(2)10-9-14-42(8,51)22-11-16-41(7)29(22)23(45)18-27-39(5)15-13-28(38(3,4)26(39)12-17-40(27,41)6)54-37-35(33(49)31(47)25(20-44)53-37)55-36-34(50)32(48)30(46)24(19-43)52-36/h10,22-37,43-51H,9,11-20H2,1-8H3/t22-,23+,24+,25+,26-,27+,28-,29-,30+,31+,32-,33-,34+,35+,36-,37-,39-,40+,41+,42-/m0/s1

InChI 密鑰

RWXIFXNRCLMQCD-JBVRGBGGSA-N

正在寻找类似产品? 访问 产品对比指南

應用

人参皂苷 Rg3 可能用于细胞信号传导研究。
人参皂苷 Rg3 用于研究其对长QT综合征(LQTS)2-人诱导多能干细胞(hiPSC-CM)中延迟整流钾电流(IKr)通道的调控作用。

生化/生理作用

人参皂苷 Rg3 是从 人参中分离得到的天然产物 。与其他人参皂甙相似,它具有心脏保护作用。人参皂甙 Rg3 通过与通道孔入口的相互作用增强心脏、hERG (IKr) 和 KCNQ (Iks) 通道电流。它还通过调节 p44/42 MAPK 活化抑制棕榈酸酯诱导的 MIN6N8 小鼠胰岛素瘤 β 细胞凋亡。人参皂苷 Rg3 提高转录因子 Nrf2 的级别,诱导多药耐药相关蛋白 (Mrp) 1 和 Mrp3 的 mRNA 水平。Rg3 通过减弱小胶质细胞对全身 LPS 处理的反应来调节神经炎症。它激活 HepG2 细胞中的 AMPK,减少脂质蓄积,从而降低血脂异常导致的心血管疾病风险。

特點和優勢

该化合物在受体分类和信号转导手册的钾通道页面上有重点介绍。想要浏览手册的其他页面, 请单击此处

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

防範說明

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Drug-mediated shortening of action potentials in LQTS2 human induced pluripotent stem cell-derived cardiomyocytes
Duncan G, et al.
Stem Cells and Development, 26(23), 1695-1705 (2017)
Seohyun Lee et al.
International journal of molecular sciences, 13(5), 5729-5739 (2012-07-04)
Cardiovascular disease (CVD) is one of the main causes of mortality worldwide, and dyslipidemia is a major risk factor for CVD. Ginseng has been widely used in the clinic to treat CVD. Ginsenoside Rg3, one of the major active components
Sang Il Gum et al.
Oxidative medicine and cellular longevity, 2013, 957947-957947 (2013-06-15)
Previously, we found that Korean red ginseng suppressed acetaminophen (APAP)-induced hepatotoxicity via alteration of its metabolic profile involving GSTA2 induction and that ginsenoside Rg3 was a major component of this gene induction. In the present study, therefore, we assessed the
Lin-Hu Quan et al.
Applied microbiology and biotechnology, 94(2), 377-384 (2012-01-18)
Microbacterium esteraromaticum was isolated from ginseng field. The β-glucosidase gene (bgp1) from M. esteraromaticum was cloned and expressed in Escherichia coli BL21 (DE3). The bgp1 gene consists of 2,496 bp encoding 831 amino acids which have homology to the glycosyl hydrolase
Chang Ki Lee et al.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 50(7), 2565-2574 (2012-01-24)
The clinical use of cisplatin (cis-diamminedichloroplatinum II) has been limited by the frequent emergence of cisplatin-resistant cell populations and numerous other adverse effects. Therefore, new agents are required to improve the therapy and health of cancer patients. Oral administration of

商品

We offer many products related to potassium channels for your research needs.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门